TCLI.F logo

Theraclion OTCPK:TCLI.F Stock Report

Last Price

US$0.59

Market Cap

US$16.7m

7D

0%

1Y

n/a

Updated

13 Dec, 2023

Data

Company Financials

TCLI.F Stock Overview

Theraclion SA develops echotherapy solutions using high intensity focused ultrasound system.

TCLI.F fundamental analysis
Snowflake Score
Valuation0/6
Future Growth0/6
Past Performance0/6
Financial Health6/6
Dividends0/6

Theraclion SA Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Theraclion
Historical stock prices
Current Share Price€0.59
52 Week High€0.59
52 Week Low€0.59
Beta0.21
1 Month Change0%
3 Month Changen/a
1 Year Changen/a
3 Year Changen/a
5 Year Changen/a
Change since IPO-60.67%

Recent News & Updates

Recent updates

Shareholder Returns

TCLI.FUS Medical EquipmentUS Market
7D0%-0.2%1.3%
1Yn/a10.6%29.8%

Return vs Industry: Insufficient data to determine how TCLI.F performed against the US Medical Equipment industry.

Return vs Market: Insufficient data to determine how TCLI.F performed against the US Market.

Price Volatility

Is TCLI.F's price volatile compared to industry and market?
TCLI.F volatility
TCLI.F Average Weekly Movementn/a
Medical Equipment Industry Average Movement7.8%
Market Average Movement6.0%
10% most volatile stocks in US Market16.8%
10% least volatile stocks in US Market3.0%

Stable Share Price: TCLI.F has not had significant price volatility in the past 3 months.

Volatility Over Time: Insufficient data to determine TCLI.F's volatility change over the past year.

About the Company

FoundedEmployeesCEOWebsite
200430Martin Deterrehttps://www.theraclion.com

Theraclion SA develops echotherapy solutions using high intensity focused ultrasound system. It offers SONOVEIN, a robotic solution for non-invasive echotherapy treatment of varicose veins; ECHOPULSE, a robotic and non-invasive solution for echotherapy treatment of thyroid nodules and breast fibroadenoma; and EPack, a disposable that is installed on the device before treatment and protects the patient’s skin and optimizes the image quality. Theraclion SA was founded in 2004 and is based in Malakoff, France.

Theraclion SA Fundamentals Summary

How do Theraclion's earnings and revenue compare to its market cap?
TCLI.F fundamental statistics
Market capUS$16.73m
Earnings (TTM)-US$5.27m
Revenue (TTM)US$2.02m

8.3x

P/S Ratio

-3.2x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
TCLI.F income statement (TTM)
Revenue€1.87m
Cost of Revenue€4.04m
Gross Profit-€2.17m
Other Expenses€2.70m
Earnings-€4.88m

Last Reported Earnings

Jun 30, 2023

Next Earnings Date

n/a

Earnings per share (EPS)-0.11
Gross Margin-116.29%
Net Profit Margin-260.94%
Debt/Equity Ratio130.1%

How did TCLI.F perform over the long term?

See historical performance and comparison
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.